Antonio Cuadrado

Affiliations: 
Bioquímica Universidad Autónoma de Madrid, Madrid, Comunidad de Madrid, Spain 
Area:
Neurosciences
Google:
"Antonio Cuadrado"
Mean distance: 106866
 
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Palomino-Antolín A, Decouty-Pérez C, Farré-Alins V, et al. (2023) Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants (Basel, Switzerland). 12
Casas AI, Nogales C, Mucke HAM, et al. (2020) On the Clinical Pharmacology of Reactive Oxygen Species. Pharmacological Reviews. 72: 801-828
Duarte P, Cuadrado A, León R. (2020) Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches. Handbook of Experimental Pharmacology
Shi L, Winchester LM, Liu BY, et al. (2020) Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad
Escoll M, Lastra D, Robledinos-Antón N, et al. (2020) WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma Cells. Antioxidants (Basel, Switzerland). 9
Lastra D, Fernández-Ginés R, Manda G, et al. (2020) Perspectives on the Clinical Development of NRF2-Targeting Drugs. Handbook of Experimental Pharmacology
Cuadrado A, Pajares M, Benito C, et al. (2020) Can Activation of NRF2 Be a Strategy against COVID-19? Trends in Pharmacological Sciences
Martin-Hurtado A, Lastres-Becker I, Cuadrado A, et al. (2020) NRF2 and Primary Cilia: An Emerging Partnership. Antioxidants (Basel, Switzerland). 9
Manda G, Rojo AI, Martínez-Klimova E, et al. (2020) Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases. Frontiers in Pharmacology. 11: 151
Herrera-Arozamena C, Estrada-Valencia M, Pérez C, et al. (2020) Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties. European Journal of Medicinal Chemistry. 190: 112090
See more...